Molecule

EPR spectroscopy is being highlighted as a way to close the 'conformation gap' in pharmaceutical and structural biology workflows. The technique can capture protein dynamics and conformational changes that methods like X-ray crystallography and cryo-EM miss, offering drug developers a fuller picture of how molecules behave in motion. Coverage discusses how integrating EPR earlier in research pipelines could improve target validation and drug design decisions.

Researchers affiliated with the American Physical Society report a new technique using quantum light to probe how solvents influence molecular behaviour. The method is said to reveal solvent effects on molecules with greater sensitivity than conventional optical approaches. Details of the study, its authors and specific findings are limited, but the work is being highlighted within the physics community as an advance in quantum-enhanced spectroscopy.

Physicists report that water confined in spaces just a few molecules wide, such as nanometer channels or between layered materials, exhibits an enormously increased dielectric permittivity compared with bulk water. The finding, highlighted by the American Physical Society, matters for understanding how water behaves inside nanoscale pores, membranes and biological structures, and could influence the design of nanofluidic devices, capacitors and filtration technologies.

A science feature is drawing attention to NAD+, the molecule often described as cellular currency because of its central role in energy production and metabolism. The piece outlines the molecule's varied biological properties and its importance to how cells function, adding to ongoing public interest in NAD+ research and its potential links to ageing and health.

Structure Therapeutics Inc., a clinical-stage biopharmaceutical company trading under the ticker GPCR, is seeing heightened interest in its stock price, news flow and trading history. The company, which focuses on oral small-molecule treatments, is being tracked by investors checking quotes and market performance. No specific new corporate development is confirmed, but the share is circulating among finance watchers.

A randomized, double-blind, placebo-controlled trial published in Nature tested safiglipron, an oral small-molecule GLP-1 receptor agonist, in people with early type 2 diabetes. Unlike injectable GLP-1 drugs such as semaglutide, safiglipron is taken as a pill, which could make treatment easier to access. The publication is drawing attention as drugmakers race to develop oral alternatives to popular injectable weight and diabetes medications.

Scientists are highlighting brine pools on the ocean floor — extremely salty underwater basins that kill most life that enters them — as potential keys to understanding how life began on Earth. The theory suggests similar chemical conditions in these pools may have driven the formation of early organic molecules, and that comparable environments could exist on other worlds, making them a target in the search for extraterrestrial life.

Researchers report that a DNA-based computer has been brought to settle in thermodynamic equilibrium, a milestone at the intersection of computing and statistical physics. The result suggests DNA molecules can perform computations while naturally relaxing toward equilibrium states, offering a way to study how energy, entropy and information interact in molecular-scale machines and potentially informing future biocomputing designs.

The Economist argues that 'mirror life' – synthetic organisms built from mirrored versions of biological molecules – would be dangerous if ever created, and calls on regulators to act before the science becomes feasible. The warning echoes a growing debate among scientists over whether research towards such organisms should be restricted.

A German-language explainer is circulating describing cannabinoids as bioactive molecules that occur mainly in the cannabis plant (phytocannabinoids) or are produced naturally by the human body. The post walks readers through the basics of how these compounds work, adding to ongoing public discussion in Germany around cannabis and its active substances.

The Economist reports that creating "mirror life" — organisms built from mirror-image versions of biological molecules — may soon be within reach of science. Such synthetic life forms, based on right-handed amino acids and left-handed DNA instead of the standard versions, could behave in unfamiliar ways. Discussion is focusing on what this would mean for biology, biotechnology safety and the risks of organisms that existing life might not be able to interact with or control.

A Wayne State University chemist has published research explaining how organisms detect carbon monoxide, a gas better known as a deadly poison but also used by cells as a signalling and energy-related molecule. The work, reported via Newswise, looks at the natural molecular sensors that respond to carbon monoxide, shedding light on how biology turns a toxic gas into a useful cellular fuel. Further details of the findings and their implications are limited.

Researchers have published a study in Nature quantifying how lipids are sorted during clathrin-mediated endocytosis, the key cellular process by which cells take in molecules from their surroundings. The work provides a detailed measurement of lipid organization at endocytic sites, offering insight into how cell membranes are organized and how cargo uptake is regulated in fundamental cell biology.

A new review in Nature examines how synthetic biology is being applied to therapeutics, covering engineered cells, redesigned molecules and biological circuits being developed to treat disease. The field is moving from lab concepts toward clinical use, raising both hopes for new treatments and questions about safety and regulation. Researchers say the approach could reshape how future medicines are designed.

Mattress brand Molecule has announced a partnership with FMG aimed at broadening its retail distribution. The deal is intended to get Molecule products in front of more consumers through additional retail channels. Details on the scope of the partnership or a timeline for expanded availability were not provided in the initial announcement.